Program News
News and stories about members of the UNC Lineberger Immunology Research Program
-
UNC Lineberger members recognized for highly cited research
Nine UNC Lineberger members wrote some of the most influential scientific papers in the past decade, according to an independent analysis of research publications.
-
UNC Lineberger shines at Carolina Hurricanes’ Hockey Fights Cancer game
H.J. Kim, MD, was honored as the Hero of the Game and Robert Ferris, MD, PhD, sounded the hurricane warning siren.
-
Miller awarded V Scholar grant to investigate approaches to boost an immune response to cancer
Brian C. Miller, MD, PhD, was named a 2024 V Foundation V Scholar. The honor will support his research focused on making cancer immunotherapy more effective.
-
Milner awarded $2.79 million NIH grant to study epigenetic regulation of T cell exhaustion
The NIH has awarded a five-year, $2.79 million R01 research grant to Justin Milner, PhD, to define how a druggable family of epigenetic regulators control T cell activity.
-
Harnessing natural killer T-cells to advance cancer immunotherapy for solid tumors
Gianpietro Dotti, MD, and Xin Zhou, PhD, report in Nature Cancer that a novel immunotherapy approach utilizing natural killer T (NKT) cells produced significant antitumor activity in solid tumors.
-
Serody and Yeh honored with Battle Distinguished Cancer Research Award
Jonathan Serody, MD, and Jen Jen Yeh, MD, were named the 2023 recipients of the Hyman L. Battle Distinguished Cancer Research Award, recognizing their significant scientific achievements.
-
Investing in named professorships to attract and retain world-class faculty
Barbara Savoldo, MD, PhD, and Stephanie Wheeler, PhD, MPH, were recently approved as named distinguished professors, one of the highest honors a university bestows to a faculty member.
-
Immune cell transformation can influence stem cell transplant success in cancer patients
Jonathan Serody, MD, Ian Davis, MD, PhD, and colleagues report ILC2s can change functions after a patient receives stem cells, thereby preventing a healthy rebuilding of the immune system.
-
Miller awarded grant to study approaches to make immunotherapy more effective against melanoma
Brian Miller, MD, PhD, is a recipient of a Melanoma Research Alliance Young Investigator Award, which will support his research focused on improving advanced melanoma’s response to immunotherapy.
-
Study reveals “cell death cascade” in airway cells infected with SARS-CoV-2
Jenny Ting, PhD, and colleagues have identified how the COVID-19 virus causes death in the cells lining the human airways.
-
Scientific symposium highlights latest developments in pancreatic cancer research
UNC Lineberger’s 47th annual scientific symposium featured 17 presentations from faculty at UNC Lineberger and institutions across the United States.
-
UNC researchers to present at American Society of Clinical Oncology annual meeting
UNC and UNC Lineberger researchers and trainees will be presenting talks and participating in scientific and educational panels and discussions on the latest cancer research at the ASCO Annual Meeting.
-
UNC School of Medicine Names 2023-24 Yang Family Biomedical Scholars
UNC Lineberger’s Pengda Liu, PhD, and Benjamin Vincent, MD, were selected as Yang Family Biomedical Scholars in the eighth installment of this annual School of Medicine award.
-
UNC researchers present at American Association for Cancer Research’s 115th Annual Meeting
Researchers and trainees from UNC and UNC Lineberger at will present more than 30 talks and participate in scientific and educational panels and discussions on the latest cancer research.
-
Newly engineered molecule bypasses toxicity previously found in key cancer-fighting pathway
UNC Lineberger researchers have developed a molecule that is much more effective than a previously identified molecule at activating a biological pathway and spurring a strong anti-cancer immune response in preclinical studies.